온라인 약국(ePharmacy) 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2022-2031년)

TMR's report on the global ePharmacy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global ePharmacy market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ePharmacy market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ePharmacy market.

The report delves into the competitive landscape of the global ePharmacy market. Key players operating in the global ePharmacy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global ePharmacy market profiled in this report.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global ePharmacy Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global ePharmacy Market Analysis and Forecast, 2017-2031

5. Key Insights

• 5.1. Pricing Analysis
• 5.2. Key Industry Events (mergers, acquisitions, collaborations, approvals, etc.)
• 5.3. COVID-19 Impact Analysis
• 5.4. Regulatory Scenario

6. Global ePharmacy Market Analysis and Forecast, by Product

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Product, 2017-2031
  • 6.3.1. Prescription Medicine
  • 6.3.2. Over-the-counter (OTC) Products
  • 6.3.3. Other (Diagnostic Services)
• 6.4. Market Attractiveness Analysis, by Product

7. Global ePharmacy Market Analysis and Forecast, by Region

• 7.1. Key Findings
• 7.2. Market Value Forecast, by Region
  • 7.2.1. North America
  • 7.2.2. Europe
  • 7.2.3. Asia Pacific
  • 7.2.4. Latin America
  • 7.2.5. Middle East & Africa
• 7.3. Market Attractiveness Analysis, by Region

8. North America ePharmacy Market Analysis and Forecast

• 8.1. Introduction
  • 8.1.1. Key Findings
• 8.2. Market Value Forecast, by Product, 2017-2031
  • 8.2.1. Prescription Medicine
  • 8.2.2. Over-the-counter (OTC) Products
  • 8.2.3. Other
• 8.3. Market Value Forecast, by Country, 2017-2031
  • 8.3.1. U.S.
  • 8.3.2. Canada
• 8.4. Market Attractiveness Analysis
  • 8.4.1. By Product
  • 8.4.2. By Country

9. Europe ePharmacy Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Key Findings
• 9.2. Market Value Forecast, by Product, 2017-2031
  • 9.2.1. Prescription Medicine
  • 9.2.2. Over-the-counter (OTC) Products
  • 9.2.3. Other
• 9.3. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 9.3.1. Germany
  • 9.3.2. U.K.
  • 9.3.3. France
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe
• 9.4. Market Attractiveness Analysis
  • 9.4.1. By Product
  • 9.4.2. By Country/Sub-region

10. Asia Pacific ePharmacy Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product, 2017-2031
  • 10.2.1. Prescription Medicine
  • 10.2.2. Over-the-counter (OTC) Products
  • 10.2.3. Other
• 10.3. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Australia & New Zealand
  • 10.3.5. Rest of Asia Pacific
• 10.4. Market Attractiveness Analysis
  • 10.4.1. By Product
  • 10.4.2. By Country/Sub-region

11. Latin America ePharmacy Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product, 2017-2031
  • 11.2.1. Prescription Medicine
  • 11.2.2. Over-the-counter (OTC) Products
  • 11.2.3. Other
• 11.3. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Market Attractiveness Analysis
  • 11.4.1. By Product
  • 11.4.2. By Country/Sub-region

12. Middle East & Africa ePharmacy Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2017-2031
  • 12.2.1. Prescription Medicine
  • 12.2.2. Over-the-counter (OTC) Products
  • 12.2.3. Other
• 12.3. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.3.1. GCC Countries
  • 12.3.2. South Africa
  • 12.3.3. Rest of Middle East & Africa
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Product
  • 12.4.2. By Country/Sub-region

13. Competition Landscape

• 13.1. Market Player - Competitive Matrix (by tier and size of companies
• 13.2. Market Share Analysis, by Company (2021)
• 13.3. Company Profiles
  • 13.3.1. Chemist Direct
    • 13.3.1.1. Company Overview
    • 13.3.1.2. Product Portfolio
    • 13.3.1.3. SWOT Analysis
    • 13.3.1.4. Financial Overview
    • 13.3.1.5. Strategic Overview
  • 13.3.2. DocMorris
    • 13.3.2.1. Company Overview
    • 13.3.2.2. Product Portfolio
    • 13.3.2.3. SWOT Analysis
    • 13.3.2.4. Financial Overview
    • 13.3.2.5. Strategic Overview
  • 13.3.3. Express Scripts Holding Company
    • 13.3.3.1. Company Overview
    • 13.3.3.2. Product Portfolio
    • 13.3.3.3. SWOT Analysis
    • 13.3.3.4. Financial Overview
    • 13.3.3.5. Strategic Overview
  • 13.3.4. Giant Eagle, Inc.
    • 13.3.4.1. Company Overview
    • 13.3.4.2. Product Portfolio
    • 13.3.4.3. SWOT Analysis
    • 13.3.4.4. Financial Overview
    • 13.3.4.5. Strategic Overview
  • 13.3.5. Healthxchange Pharmacy
    • 13.3.5.1. Company Overview
    • 13.3.5.2. Product Portfolio
    • 13.3.5.3. SWOT Analysis
    • 13.3.5.4. Financial Overview
    • 13.3.5.5. Strategic Overview
  • 13.3.6. LloydsPharmacy
    • 13.3.6.1. Company Overview
    • 13.3.6.2. Product Portfolio
    • 13.3.6.3. SWOT Analysis
    • 13.3.6.4. Financial Overview
    • 13.3.6.5. Strategic Overview
  • 13.3.7. MedExpress
    • 13.3.7.1. Company Overview
    • 13.3.7.2. Product Portfolio
    • 13.3.7.3. SWOT Analysis
    • 13.3.7.4. Financial Overview
    • 13.3.7.5. Strategic Overview
  • 13.3.8. Netmeds
    • 13.3.8.1. Company Overview
    • 13.3.8.2. Product Portfolio
    • 13.3.8.3. SWOT Analysis
    • 13.3.8.4. Financial Overview
    • 13.3.8.5. Strategic Overview
  • 13.3.9. Optum Rx, Inc.
    • 13.3.9.1. Company Overview
    • 13.3.9.2. Product Portfolio
    • 13.3.9.3. SWOT Analysis
    • 13.3.9.4. Financial Overview
    • 13.3.9.5. Strategic Overview
  • 13.3.10. PharmEasy
    • 13.3.10.1. Company Overview
    • 13.3.10.2. Product Portfolio
    • 13.3.10.3. SWOT Analysis
    • 13.3.10.4. Financial Overview
    • 13.3.10.5. Strategic Overview
  • 13.3.11. 1Mg
    • 13.3.11.1. Company Overview
    • 13.3.11.2. Product Portfolio
    • 13.3.11.3. SWOT Analysis
    • 13.3.11.4. Financial Overview
    • 13.3.11.5. Strategic Overview
  • 13.3.12. Rowlands Pharmacy
    • 13.3.12.1. Company Overview
    • 13.3.12.2. Product Portfolio
    • 13.3.12.3. SWOT Analysis
    • 13.3.12.4. Financial Overview
    • 13.3.12.5. Strategic Overview
  • 13.3.13. The Kroger Co.
    • 13.3.13.1. Company Overview
    • 13.3.13.2. Product Portfolio
    • 13.3.13.3. SWOT Analysis
    • 13.3.13.4. Financial Overview
    • 13.3.13.5. Strategic Overview
  • 13.3.14. Walgreen Co.
    • 13.3.14.1. Company Overview
    • 13.3.14.2. Product Portfolio
    • 13.3.14.3. SWOT Analysis
    • 13.3.14.4. Financial Overview
    • 13.3.14.5. Strategic Overview
  • 13.3.15. Well Pharmacy
    • 13.3.15.1. Company Overview
    • 13.3.15.2. Product Portfolio
    • 13.3.15.3. SWOT Analysis
    • 13.3.15.4. Financial Overview
    • 13.3.15.5. Strategic Overview